Tempo Bioscience is featured as the Cover Story in the 2021 Top10 Biotech Startups by Pharma Tech Outlook. Click here for the digital issue.
Tempo Bioscience Expands Patient-Relevant iPSC-Derived Cell Models
- Tempo-iSchwann™ Human iPSC-derived Schwann Cells
- Tempo-iCardio™ Human iPSC-derived Cardiomyocytes
- Tempo-iKidneyPod™ Human iPSC-derived Kidney Proximal Tubules & Podocytes 3D Spheroids
- Tempo-iMono™ Human iPSC-derived CD14+ Monocytes
- Tempo-iPhago™ Human iPSC-derived Phagocytes
(Announcement via BusinessWire here)
Continue Reading...